📣 On #WorldHealthDay, the EHC calls on EU policymakers to get the #EUBiotechAct right — with #Patients with #BleedingDisorders at the centre, real-world evidence & cross-border #ClinicalTrials. #StandWithScience 👉 buff.ly/rQxzkpz

@who.int

European Biotech Act: Impact on Phase I Clinical Research | Niche Analysis of the EU Biotech Act and its implications for early clinical pharmacology, Phase I trials and innovation competitiveness in Europe and the UK.

🚀 Europe’s EU Biotech Act could rewrite the rules for innovation — faster trials, stronger funding, and a competitive edge for biotech! 🌍🧬 Ready to boost R&D across the Union and beyond niche.org.uk/eu-biotech-act #EUbiotechAct #LifeSciences #Innovation

Rare diseases: a testbed for health innovation Over 30 million people in Europe live with a rare disease. Most of them still lack access to accurate diagnosis or treatment options. These unmet needs, these “white spots”, are not fringe issues.…

💡 #RareDiseaseMoonshot

As Europe discusses the future of life sciences in the context of the #EUBiotechAct, the #RareDisease Moonshot’s proposals will strengthen innovation for improved health outcomes and drive Europe’s competitiveness in life sciences

🔗 News article: buff.ly/mEC7Fet

🧵 10/12

Close-up of a pipette releasing a blue liquid drop into a clear well in a laboratory test tray.

🧬 The #EUBiotechAct represents a key opportunity to address barriers and ensure that innovation translates into both improved patient outcomes and industrial resilience.

🗓️ Have your say in the public consultation before 10 November.

🔗 Read more: https://go.eurordis.org/BiotechAct

Viewpoint: a strong EU Biotech Act is vital for Europe’s synthetic biology industry The enhanced ability to synthesise DNA, RNA and peptides has transformed biotechnology, enabling tremendous advances in medicine, agriculture and manufacturing. However, unverified access to certain…

The #EUBiotechAct isn’t just about regulation it’s about Europe’s place in global #SyntheticBiology. One framework for innovation, safety, and competitiveness.

📌 Read the full story here:

FirstWord

#lifesciences #EFPIA #intellectualproperty #clinicaltrials #marketaccess #lifescienceinnovations #EUBiotechAct #biotech #biotechdevelopment #biotechinnovations #innovativemedicines #intellectualpropertyframework #pharmaceuticalRandD #ClinicalResearch
firstwordpharma.com/story/5977924

💡 #RareDiseaseMoonshot

The Rare Disease Moonshot welcomes the European Commission’s ambition to develop a comprehensive #EUBiotechAct.

🔗 Read more: buff.ly/EbEvIkm

🧵 12/13

Biotech is a key driver for a strong and united Europe

We welcome the @ec.europa.eu Commission Work Programme 2025 published yesterday.
While we support necessary cluster policy and legislative actions, we are committed for a bold #EUBiotechAct to unleash European prosperity, resilience and global leadership.
Our full reaction at: shorturl.at/oOvWQ

Biomanufacturing: Europe’s Industrial Future

#Biomanufacturing can provide new sustainable technologies and ensure industries' competitiveness.
The #EUBiotechAct with other clusters will need a strategic vision for biomanufacturing future in Europe.

🔗 You can read Our "Biomanufacturing: Europe's Industrial Future" at: shorturl.at/wfxaE

The EU Biotech Act – EuropaBio Vision Paper

EuropaBio's vision for a bold #EUBiotechAct is out today!

The paper calls for an Act strengthening value chains from R&D to end-users, creating coherent regulatory pathways and building a next-generation ecosystem.

🔗Read the full paper now and download it at: www.europabio.org/the-eu-biote...